Abstract
Background: Alopecia areata (AA) is an immune-mediated form of hair loss that affects all ages and both sexes.Paraoxonase 1 (PON1) is an esterase enzyme that has lipophilic antioxidant power; it is one of the endogenousfree-radical-scavenging systems in the human body. This work was to detect serum PON1 level in patients withalopecia areata.Methods: 60 subjects, 30 AA patients and 30 controls. Full history, general and local clinical examination, clinicalassessment of the degree of AA and collection of blood for investigations and paraoxonase1 measurement wereto participants.Results: The study revealed significant decrease in serum PON1 level in AA patients (54.083 ± 25.464 μg/L) incomparison to controls (69.479 ± 17.012 μg/L). This decrease was more in male than female.Conclusions: Serum PON1 levels are lower in AA patients. An association between oxidative stress andpathogenesis of this auto immune disease is identified. Attenuation of oxidative stress might be a relevanttherapeutic approach and it would be useful to recommend additional drugs with antioxidant effect for treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
